PRCT in the 13F filings
Procept Biorobotics Corp · CUSIP 74276L105
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 2 Sep 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 24
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 2 listed it in both
- Shares listed
- 9,480,800
- combined, among listed positions
- Reported value
- $214m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 15 buyers (opened or added shares) and 12 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -690,362.
Managers listing PRCT in Q2 2026
24 of 24 holders
Largest increases and reductions, by shares
Increases
- T. Rowe Price Associates Incexisting position · 1,332,452 shares now+726,494
- Janus Henderson Group Ltdexisting position · 1,103,404 shares now+719,158
- Wellington Management Group LLPexisting position · 1,274,004 shares now+412,399
- AQR Capital Management LLCexisting position · 370,455 shares now+114,604
- ExodusPoint Capital Management LPnew position · 96,376 shares now+96,376
Reductions
- Artisan Partners LPexisting position · 682,588 shares now-504,761
- Marshall Wace LLPexisting position · 297,159 shares now-401,073
- Millennium Management LLCexisting position · 624,312 shares now-381,146
- Two Sigma Investments LPexisting position · 51,003 shares now-177,508
- AllianceBernstein LPexisting position · 60,470 shares now-86,857
New positions and exits
New (5)
Exited (3)
- Point72 Asset Management LPwas $28m
- Renaissance Technologies LLCwas $2.9m
- Quantbot Technologies LPwas $2.0m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2021 | 4 | $191m | n.a. | n.a. |
| Q4 2021 | 3 | $124m | n.a. | n.a. |
| Q1 2022 | 2 | $128m | n.a. | n.a. |
| Q2 2022 | 2 | $51m | n.a. | n.a. |
| Q3 2022 | 1 | $16k | n.a. | n.a. |
| Q4 2022 | 2 | $768k | n.a. | n.a. |
| Q1 2023 | 3 | $11m | n.a. | n.a. |
| Q2 2023 | 1 | $1.8m | n.a. | n.a. |
| Q3 2023 | 1 | $1.4m | n.a. | n.a. |
| Q4 2023 | 3 | $103m | 2 | 1 |
| Q1 2024 | 5 | $129m | 2 | 2 |
| Q2 2024 | 6 | $610m | 4 | 2 |
| Q3 2024 | 5 | $768m | 1 | 4 |
| Q4 2024 | 9 | $1.0bn | 8 | 1 |
| Q1 2025 | 6 | $718m | 5 | 1 |
| Q2 2025 | 3 | $232m | 3 | 0 |
| Q3 2025 | 3 | $201m | 2 | 1 |
| Q4 2025 | 4 | $194m | 17 | 10 |
| Q1 2026 | 3 | $56m | 13 | 15 |
| Q2 2026 | 2 | $36m | 15 | 12 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
PRCT and LLY →PRCT and JNJ →PRCT and VRTX →Choose a stock to compare with PRCT →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own PRCT, latest filings →Back to the 13F Explorer →